BookDaan J.A. Crommelin, Jon S.B. de Vlieger, editors.
Contents:
Introduction: defining the position of non-biological complex drugs
Polymeric micelles
Liposomes: the science and the regulatory landscape
Glatiramoids
Iron carbohydrate complexes: characteristics and regulatory challenges
Drug nanocrystals
Analytical methods for determining the size (distribution) in parenteral dispersions
NBCD pharmacokinetics and bioanalytical methods to meaure drug release
Low molecular weight heparins, biological drugs close to non-biological complex drugs
Nanoparticle albumin-bound anticancer agents
The EU regulatory landscape of non-biological complex drugs
Epilogue: What did we learn? What can we expect in the future? Concluding remarks and outstanding issues
Index.